{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:05:50Z","timestamp":1792037150250,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100015034","name":"shahid sadoughi university of medical sciences","doi-asserted-by":"crossref","award":["8986"],"award-info":[{"award-number":["8986"]}],"id":[{"id":"10.13039\/501100015034","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AMB Expr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Leishmaniasis is one of the common diseases transmitted by sand flies in tropical and subtropical regions of the world. Currently, antimonial derivatives are the first line of treatment. Some of the members of the ATP-binding cassette (ABC) family of<jats:italic>Leishmania<\/jats:italic>are shown to be associated with no response to treatment. In this study, we evaluated<jats:italic>ABCI4<\/jats:italic>,<jats:italic>ABCG2, ABCC7, ABCB4<\/jats:italic>, and<jats:italic>ABCC3<\/jats:italic>genes expression in<jats:italic>Leishmania<\/jats:italic>isolated from patients with non-healing cutaneous leishmaniasis and treatment response isolates. We selected 17 clinical isolates including 8 treatment failure and 9 treatment response samples from September 2020 to March 2021. The isolates were obtained from patients of Health Center Laboratory of Varzaneh, Isfahan, Iran with cutaneous leishmaniasis. The diagnosis was performed using microscopic observation. The samples were directly collected from the lesions. The expression profiling of genes was assessed using SYBR Green real-time PCR that was analyzed with delta-delta Ct. All treatment failure clinical isolates were<jats:italic>L. major<\/jats:italic>. Gene expression analysis in treatment failure isolates showed that the ABC transported genes had a different pattern in each isolate. Treatment failure has been reported for cutaneous leishmaniasis worldwide. Knowledge of the molecular mechanisms of treatment failure could solve this problem. ABC transporter genes are considered controversial over the mechanisms of treatment failure outcomes. In this study, we showed that ABC transporter genes could be considered one of the important mechanisms.<\/jats:p>","DOI":"10.1186\/s13568-022-01419-5","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T18:02:59Z","timestamp":1655402579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The role of ATP-binding cassette transporter genes expression in treatment failure cutaneous leishmaniasis"],"prefix":"10.1186","volume":"12","author":[{"given":"Mohammad Javad","family":"Boozhmehrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4521-4059","authenticated-orcid":false,"given":"Gilda","family":"Eslami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Khamesipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas Ali","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Vakili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeedeh Sadat","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahideh","family":"Askari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"key":"1419_CR1","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, V\u00e9lez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M, WHO Leishmaniasis Control Team (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE 7:e35671. https:\/\/doi.org\/10.1371\/journal.pone.0035671","journal-title":"PLoS ONE"},{"key":"1419_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-018-5260-9","volume":"18","author":"I Bennis","year":"2018","unstructured":"Bennis I, De Brouwere V, Belrhiti Z, Sahibi H, Boelaert M (2018) Psychosocial burden of localised cutaneous leishmaniasis: a scoping review. BMC Public Health 18:1\u201312. https:\/\/doi.org\/10.1186\/s12889-018-5260-9","journal-title":"BMC Public Health"},{"key":"1419_CR3","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1128\/AAC.47.10.3073-3079.2003","volume":"47","author":"C Brochu","year":"2003","unstructured":"Brochu C, Wang J, Roy G, Messier N, Wang X-Y, Saravia NG, Ouellette M (2003) Antimony uptake systems in the protozoan parasite Leishmania and accumulation differences in antimony-resistant parasites. Antimicrob Agents Chemother 47:3073\u20133079. https:\/\/doi.org\/10.1128\/AAC.47.10.3073-3079.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"1419_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0166-6851(94)00154-5","volume":"68","author":"HL Callahan","year":"1994","unstructured":"Callahan HL, Roberts WL, Rainey PM, Beverley SM (1994) The PGPA gene of Leishmania major mediates antimony (SbIII) resistance by decreasing influx and not by increasing efflux. Mol Biochem Parasitol 68:145\u2013149. https:\/\/doi.org\/10.1016\/0166-6851(94)00154-5","journal-title":"Mol Biochem Parasitol"},{"key":"1419_CR5","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1128\/AAC.00587-08","volume":"52","author":"E Castanys-Munoz","year":"2008","unstructured":"Castanys-Munoz E, Perez-Victoria JM, Gamarro F, Castanys S (2008) Characterization of an ABCG like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement. Antimicrob Agents Chemother 52:3573\u20133579. https:\/\/doi.org\/10.1128\/AAC.00587-08","journal-title":"Antimicrob Agents Chemother"},{"key":"1419_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0166-6851(03)00162-2","volume":"130","author":"AC Coelho","year":"2003","unstructured":"Coelho AC, Beverley SM, Cotrim PC (2003) Functional genetic identification of PRP1, an ABC transporter superfamily member conferring pentamidine resistance in Leishmania major. Mol Biochem Parasitol 130:83\u201390. https:\/\/doi.org\/10.1016\/S0166-6851(03)00162-2","journal-title":"Mol Biochem Parasitol"},{"key":"1419_CR7","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1128\/AAC.00404-07","volume":"51","author":"AC Coelho","year":"2007","unstructured":"Coelho AC, Messier N, Ouellette M, Cotrim PC (2007) Role of the ABC transporter PRP1 (ABCC7) in pentamidine resistance in Leishmania amastigotes. Antimicrob Agents Chemother 51:3030\u20133032. https:\/\/doi.org\/10.1128\/AAC.00404-07","journal-title":"Antimicrob Agents Chemother"},{"key":"1419_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","volume":"19","author":"SL Croft","year":"2006","unstructured":"Croft SL, Sundar S, Fairlamb AH (2006) Drug resistance in leishmaniasis. Clin Microbiol Rev 19:111\u2013126. https:\/\/doi.org\/10.1128\/CMR.19.1.111-126.2006","journal-title":"Clin Microbiol Rev"},{"key":"1419_CR9","doi-asserted-by":"publisher","first-page":"e1514","DOI":"10.1371\/journal.pntd.0001514","volume":"6","author":"S Decuypere","year":"2012","unstructured":"Decuypere S, Vanaerschot M, Brunker K, Imamura H, M\u00fcller S, Khanal B, Rijal S, Dujardin JC, Coombs GH (2012) Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background. PLoS Negl Trop Dis 6:e1514. https:\/\/doi.org\/10.1371\/journal.pntd.0001514","journal-title":"PLoS Negl Trop Dis"},{"key":"1419_CR10","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1128\/AAC.49.5.1988-1993.2005","volume":"49","author":"K El Fadili","year":"2005","unstructured":"El Fadili K, Messier N, Leprohon P, Roy G, Guimond C, Trudel N, Saravia NG, Papadopoulou B, Legare D, Ouellete M (2005) Role of the ABC transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes. Antimicrob Agents Chemother 49:1988\u20131993. https:\/\/doi.org\/10.1128\/AAC.49.5.1988-1993.2005","journal-title":"Antimicrob Agents Chemother"},{"key":"1419_CR11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4103\/0972-9062.197272","volume":"53","author":"G Eslami","year":"2016","unstructured":"Eslami G, Zarchi MV, Moradi A, Hejazi SH, Sohrevardi SM, Vakili M, Khamesipour A (2016) Aquaglyceroporin1 gene expression in antimony resistance and susceptible Leishmania major isolates. J Vector Borne Dis 53:370","journal-title":"J Vector Borne Dis"},{"key":"1419_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1186\/s13104-019-4784-0","volume":"12","author":"M Fekrisoofiabadi","year":"2019","unstructured":"Fekrisoofiabadi M, Fekri M, Moradabadi A, Vahidi R, Khaleghi M, Ram M, Dabiri S (2019) Evaluation of MDR1 and MRPA genes expression in different types of dry cutaneous leishmaniasis. BMC Res Notes 12:803. https:\/\/doi.org\/10.1186\/s13104-019-4784-0","journal-title":"BMC Res Notes"},{"key":"1419_CR13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1080\/09546634.2019.1704214","volume":"32","author":"A Firooz","year":"2020","unstructured":"Firooz A, Mortazavi H, Khamesipour A, Ghiasi M, Abedini R, Balighi K, Esmaili N, Nassiri-Kashani M, Eskandari SE, Moheballi M, Mir Amin Mohammadi A, Dowlati Y (2020) Old world cutaneous leishmaniasis in Iran: clinical variants and treatments. J Dermatol Treat 32:673\u2013686. https:\/\/doi.org\/10.1080\/09546634.2019.1704214","journal-title":"J Dermatol Treat"},{"key":"1419_CR14","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.1371\/journal.pmed.0030162","volume":"3","author":"R Hadighi","year":"2006","unstructured":"Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A, Ouellette M (2006) Unresponsiveness to glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS Med 3:e162. https:\/\/doi.org\/10.1371\/journal.pmed.0030162","journal-title":"PLoS Med"},{"key":"1419_CR15","doi-asserted-by":"publisher","first-page":"571242","DOI":"10.4061\/2011\/571242","volume":"2011","author":"AK Haldar","year":"2011","unstructured":"Haldar AK, Sen P, Roy S (2011) Use of antimony in the treatment of leishmaniasis: current status and future directions. Mol Biol Int 2011:571242. https:\/\/doi.org\/10.4061\/2011\/571242","journal-title":"Mol Biol Int"},{"key":"1419_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1055\/s-0034-1370914","volume":"65","author":"R Jabini","year":"2015","unstructured":"Jabini R, Jaafari M, Hasani FV, Ghazizadeh F, Khamesipour A, Karimi G (2015) Effects of combined therapy with silymarin and glucantime on leishmaniasis induced by Leishmania major in BALB\/c mice. Drug Res 65:119\u2013124. https:\/\/doi.org\/10.1055\/s-0034-1370914","journal-title":"Drug Res"},{"key":"1419_CR17","doi-asserted-by":"publisher","first-page":"363","DOI":"10.18502\/jad.v14i4.5274","volume":"14","author":"Z Kakooei","year":"2020","unstructured":"Kakooei Z, Hajjaran H, Akhoundi B, Charehdar S, Elikaee S, Shafeghat Z, Hassanpour H, Satvat MT, Kazemi-Rad E, Mohebali M (2020) Treatment failure in cutaneous leishmaniasis patients referred to the School of Public Health, Tehran University of Medical Sciences during 2008\u20132017. J Arthropod Borne Dis 14:363\u2013375. https:\/\/doi.org\/10.18502\/jad.v14i4.5274","journal-title":"J Arthropod Borne Dis"},{"key":"1419_CR18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.exppara.2013.07.018","volume":"135","author":"E Kazemi-Rad","year":"2013","unstructured":"Kazemi-Rad E, Mohebali M, Khadem-Erfan MB, Saffari M, Raoofian R, Hajjaran H, Hadighi R, Khamesipour A, Rezaie S, Abedkhpjasteh H, Heidari M (2013) Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach. Exp Parasitol 135:344\u2013349. https:\/\/doi.org\/10.1016\/j.exppara.2013.07.018","journal-title":"Exp Parasitol"},{"key":"1419_CR19","doi-asserted-by":"publisher","first-page":"26301","DOI":"10.1074\/jbc.M102351200","volume":"276","author":"D L\u00e9gar\u00e9","year":"2001","unstructured":"L\u00e9gar\u00e9 D, Richard D, Mukhopadhyay R, Stierhof Y-D, Rosen BP, Haimeur A, Papadopoulou B, Ouellette M (2001) The Leishmania ATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase. J Biol Chem 276:26301\u201326307. https:\/\/doi.org\/10.1074\/jbc.M102351200","journal-title":"J Biol Chem"},{"key":"1419_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ijpddr.2014.09.005","volume":"5","author":"P Leprohon","year":"2015","unstructured":"Leprohon P, Fernandez-Prada C, Gazanion \u00c9, Monte-Neto R, Ouellette M (2015) Drug resistance analysis by next generation sequencing in Leishmania. Int J Parasitol Drugs Drug Resist 5:26\u201335. https:\/\/doi.org\/10.1016\/j.ijpddr.2014.09.005","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"1419_CR21","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1128\/EC.00152-06","volume":"5","author":"P Leprohon","year":"2006","unstructured":"Leprohon P, L\u00e9gar\u00e9 D, Girard I, Papadopoulou B, Ouellette M (2006) Modulation of Leishmania ABC protein gene expression through life stages and among drug-resistant parasites. Eukaryot cell 5:1713\u20131725. https:\/\/doi.org\/10.1128\/EC.00152-06","journal-title":"Eukaryot cell"},{"key":"1419_CR22","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1128\/AAC.01474-08","volume":"53","author":"P Leprohon","year":"2009","unstructured":"Leprohon P, L\u00e9gar\u00e9 D, Ouellette M (2009) Intracellular localization of the ABCC proteins of Leishmania and their role in resistance to antimonials. Antimicrob Agents Chemother 53:2646\u20132649. https:\/\/doi.org\/10.1128\/AAC.01474-08","journal-title":"Antimicrob Agents Chemother"},{"key":"1419_CR23","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1128\/AAC.00211-13","volume":"57","author":"JI Manzano","year":"2013","unstructured":"Manzano JI, Garc\u00eda-Hern\u00e1ndez R, Castanys S, Gamarro F (2013) A new ABC half-transporter in Leishmania major is involved in resistance to antimony. Antimicrob Agents Chemother 57:3719\u20133730. https:\/\/doi.org\/10.1128\/AAC.00211-13","journal-title":"Antimicrob Agents Chemother"},{"key":"1419_CR24","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/jac\/dkt407","volume":"69","author":"JI Manzano","year":"2014","unstructured":"Manzano JI, Lecerf-Schmidt F, Lespinasse MA, Di Pietro A, Castanys S, Boumendjel A, Gamarro F (2014) Identification of specific reversal agents for Leishmania ABCI4-mediated antimony resistance by flavonoid and trolox derivatives screening. J Antimicrob Agents 69:664\u2013672. https:\/\/doi.org\/10.1093\/jac\/dkt407","journal-title":"J Antimicrob Agents"},{"key":"1419_CR25","doi-asserted-by":"publisher","first-page":"ofaa155","DOI":"10.1093\/ofid\/ofaa155","volume":"7","author":"DY Mart\u00ednez","year":"2020","unstructured":"Mart\u00ednez DY, Llanos-Cuentas A, Dujardin JC, Polman K, Adaui V, Boelaert M, Verdonck K (2020) A case\u2013control study on the association between intestinal helminth infections and treatment failure in patients with cutaneous leishmaniasis. Open Forum Infect Dis 7:ofaa155. https:\/\/doi.org\/10.1093\/ofid\/ofaa155","journal-title":"Open Forum Infect Dis"},{"key":"1419_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/jac\/dkl494","volume":"59","author":"A Mukherjee","year":"2007","unstructured":"Mukherjee A, Padmanabhan PK, Singh S, Roy G, Girard I, Chatterjee M, Ouellette M, Madhubala R (2007) Role of ABC transporter MRPA, \u03b3-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani. J Antimicrob Chemother 59:204\u2013211. https:\/\/doi.org\/10.1093\/jac\/dkl494","journal-title":"J Antimicrob Chemother"},{"key":"1419_CR27","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.apjtb.2016.05.005","volume":"6","author":"F Norouzinezhad","year":"2016","unstructured":"Norouzinezhad F, Ghaffari F, Norouzinejad A, Kaveh F, Gouya MM (2016) Cutaneous leishmaniasis in Iran: results from an epidemiological study in urban and rural provinces. Asian Pac J Trop Biomed 6:614\u2013619. https:\/\/doi.org\/10.1016\/j.apjtb.2016.05.005","journal-title":"Asian Pac J Trop Biomed"},{"key":"1419_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1368-7646(98)80213-6Get","volume":"1","author":"M Ouellette","year":"1998","unstructured":"Ouellette M, Legare D, Haimeur A, Grondin K, Roy G, Brochu C, Papadopoulou B (1998) ABC transporters in Leishmania and their role in drug resistance. Drug Resist Updat 1:43\u201348. https:\/\/doi.org\/10.1016\/S1368-7646(98)80213-6Get","journal-title":"Drug Resist Updat"},{"key":"1419_CR29","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1128\/AAC.02813-15","volume":"60","author":"A Perea","year":"2016","unstructured":"Perea A, Manzano JI, Castanys S, Gamarro F (2016) The LABCG2 transporter from the protozoan parasite Leishmania is involved in antimony resistance. Antimicrob Agents Chemother 60:3489\u20133496. https:\/\/doi.org\/10.1128\/AAC.02813-15","journal-title":"Antimicrob Agents Chemother"},{"key":"1419_CR30","doi-asserted-by":"publisher","first-page":"e0006052","DOI":"10.1371\/journal.pntd.0006052","volume":"11","author":"A Ponte-Sucre","year":"2017","unstructured":"Ponte-Sucre A, Gamarro F, Dujardin JC, Barrett MP, L\u00f3pez-V\u00e9lez R, Garc\u00eda-Hern\u00e1ndez R, Pountain AW, Mwenechanya R, Papadopoulou B (2017) Drug resistance and treatment failure in leishmaniasis: A 21st century challenge. PLoS Negl Trop Dis 11:e0006052. https:\/\/doi.org\/10.1371\/journal.pntd.0006052","journal-title":"PLoS Negl Trop Dis"},{"key":"1419_CR31","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1128\/AAC.00030-11","volume":"56","author":"B Purkait","year":"2012","unstructured":"Purkait B, Kumar A, Nandi N, Sardar AH, Das S, Kumar S, De T, Singh D, Das P (2012) Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani. Antimicrob Agents Chemother 56:1031\u20131041. https:\/\/doi.org\/10.1128\/AAC.00030-11","journal-title":"Antimicrob Agents Chemother"},{"key":"1419_CR32","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ijpddr.2018.04.002","volume":"8","author":"A Rastrojo","year":"2018","unstructured":"Rastrojo A, Garc\u00eda-Hern\u00e1ndez R, Vargas P, Camacho E, Corvo L, Imamura H, Dujardin JC, Castanys S, Aguado B, Gamarro F, Requena JM (2018) Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs. Int J Parasitol Drugs Drug Resist 8:246\u2013264. https:\/\/doi.org\/10.1016\/j.ijpddr.2018.04.002","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"1419_CR33","doi-asserted-by":"publisher","first-page":"e190111","DOI":"10.1590\/0074-02760190111","volume":"114","author":"JN Rugani","year":"2019","unstructured":"Rugani JN, Gontijo CMF, Fr\u00e9zard F, Soares RP, Monte-Neto RLD (2019) Antimony resistance in Leishmania (Viannia) braziliensis clinical isolates from atypical lesions associates with increased ARM56\/ARM58 transcripts and reduced drug uptake. Mem Inst Oswaldo Cruz 114:e190111. https:\/\/doi.org\/10.1590\/0074-02760190111","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1419_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s11686-021-00463-8","author":"R Somee","year":"2021","unstructured":"Somee R, Eslami G, Vakili M (2021) Mitogen-activated protein kinase and aquaglyceroporin gene expression in treatment failure Leishmania major. Acta Parasitol. https:\/\/doi.org\/10.1007\/s11686-021-00463-8","journal-title":"Acta Parasitol"},{"key":"1419_CR35","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1586\/14787210.2014.916614","volume":"12","author":"M Vanaerschot","year":"2014","unstructured":"Vanaerschot M, Dumetz F, Roy S, Ponte-Sucre A, Arevalo J, Dujardin JC (2014) Treatment failure in leishmaniasis: drug-resistance or another (epi-). phenotype? Expert Rev Anti Infect Ther 12:937\u2013946. https:\/\/doi.org\/10.1586\/14787210.2014.916614","journal-title":"phenotype? Expert Rev Anti Infect Ther"},{"key":"1419_CR36","unstructured":"WHO (2020) Leishmaniasis: status of endemicity of cutaneous leishmaniasis (2020). https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/gho-ntd-leishmaniasis"}],"container-title":["AMB Express"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-022-01419-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13568-022-01419-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-022-01419-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T02:15:43Z","timestamp":1727403343000},"score":1,"resource":{"primary":{"URL":"https:\/\/amb-express.springeropen.com\/articles\/10.1186\/s13568-022-01419-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1419"],"URL":"https:\/\/doi.org\/10.1186\/s13568-022-01419-5","relation":{},"ISSN":["2191-0855"],"issn-type":[{"value":"2191-0855","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,16]]},"assertion":[{"value":"2 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical statement of this study was approved by the Ethical Committee for Shahid Sadoughi University of Medical Sciences with the code of IR. SSU. MEDICINE. REC. 1399.194. This project was approved by Shahid Sadoughi University of Medical Sciences, Yazd, Iran, by the code of 8986.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from patients. In the case of children, their parent or legal guardian assigned the consent form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}